Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,820 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
Pakpoor J, Disanto G, Altmann DR, Pavitt S, Turner BP, Marta M, Juliusson G, Baker D, Chataway J, Schmierer K. Pakpoor J, et al. Among authors: baker d. Neurol Neuroimmunol Neuroinflamm. 2015 Oct 1;2(6):e158. doi: 10.1212/NXI.0000000000000158. eCollection 2015 Dec. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26468472 Free PMC article.
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.
Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, Knappertz V, Tomic D, Leppert D, Herndon R, Wheeler-Kingshott CAM, Ciccarelli O, Selwood D, di Cantogno EV, Ben-Amor AF, Matthews P, Carassiti D, Baker D, Schmierer K. Giovannoni G, et al. Among authors: baker d. Mult Scler Relat Disord. 2017 Feb;12:70-78. doi: 10.1016/j.msard.2017.01.007. Epub 2017 Jan 17. Mult Scler Relat Disord. 2017. PMID: 28283111 Free article. Review.
Axonal loss in the multiple sclerosis spinal cord revisited.
Petrova N, Carassiti D, Altmann DR, Baker D, Schmierer K. Petrova N, et al. Among authors: baker d. Brain Pathol. 2018 May;28(3):334-348. doi: 10.1111/bpa.12516. Epub 2017 May 7. Brain Pathol. 2018. PMID: 28401686 Free PMC article.
Both cladribine and alemtuzumab may effect MS via B-cell depletion.
Baker D, Herrod SS, Alvarez-Gonzalez C, Zalewski L, Albor C, Schmierer K. Baker D, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5;4(4):e360. doi: 10.1212/NXI.0000000000000360. eCollection 2017 Jul. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28626781 Free PMC article.
Disease modification in advanced MS: Focus on upper limb function.
Dubuisson N, Baker D, Thomson A, Marta M, Gnanapavan S, Turner B, Giovannoni G, Schmierer K. Dubuisson N, et al. Among authors: baker d. Mult Scler. 2017 Dec;23(14):1956-1957. doi: 10.1177/1352458517717811. Epub 2017 Jul 3. Mult Scler. 2017. PMID: 28669257 No abstract available.
5,820 results